The central government has asked the Serum Institute of India and Bharat Biotech to lower the price of COVID vaccines, Covishield and Covaxin as India gears up to vaccinate all aged above 18 from May 1, official sources said on Monday.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Centre asks Serum Institute, Bharat Biotech to lower prices of Covishield, Covaxin: Sources.
The central government has asked the Serum Institute of India and Bharat Biotech to lower the price of COVID vaccines, Covishield and Covaxin as India gears up to vaccinate all aged above 18 from May 1, official sources said on Monday.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Centre asks Serum Institute, Bharat Biotech to lower prices of Covishield, Covaxin: Sources
News video | 447 views
Bharat Biotech reduces Covaxin price for state governments by Rs 200, dose now at Rs 400. Earlier, each dose was priced at Rs 600. Watch
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
The Economic Times | A Times Internet Limited product
Covaxin prices slashed, Bharat Biotech to sell vaccine to state governments at Rs 400 per dose
News video | 314 views
Amid reports of Covid-19 vaccine shortage across the country, the Modi government has refused to allow Serum Institute of India (SII) to export around 50 lakh doses of Covishield vaccine to the United Kingdom. While rejecting SII’s request, the central government insisted that the local vaccine production be supplied to protect Indians first.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Govt rejects Serum Institute of India’s request to export 50 lakh doses of Covishield vaccine to UK
News video | 500 views
Serum Institute ने कोविशील्ड का घटाया दाम, राज्यों को अब 300 में मिलेगी कोरोना की वैक्सीन
Visit Us - http://www.inhnews.in/
Follow Us On Twitter - https://twitter.com/inhnewsindia
Our WhatsApp Number - 9993022843
Link - https://youtu.be/XVOd1wWkhx8
Incoming Search Terms,
#COVIDSecondWave #CoronavirusVaccine
COVID-19 Vaccine News,
Corona Vaccine,
Covid-19 vaccination,
Corona Vaccine In India,
COVID-19 Vaccine in India,
COVID-19 vaccination in India,
COVID Second Wave in India,
Corona Second Wave,
Corona Virus Outbreak in India,
Corona Virus in India,
Latest News,
Covishield Price Drop : Serum Institute ने कोविशील्ड का घटाया दाम, 300 में मिलेगी कोरोना की वैक्सीन
News video | 277 views
Serum Institute of India (SII), the world's largest vaccine maker, on Wednesday announced a price of Rs 600 per dose for COVID vaccine supplies to private hospitals and Rs 400 per dose to state governments. In a statement posted on its Twitter handle, SII said it will address the limited capacity by scaling up the vaccine production over the next two months.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Serum fixes 'Covishield' prices at Rs 400 per dose for state govts, Rs 600 for private hospitals
News video | 709 views
कोरोनावायरस : भारत में कोरोनावायरस संक्रमण की तीसरी लहर इस साल सर्दियों के मौसम यानी नवंबर के अंत और दिसंबर की शुरुआत में आने की संभावना है। हेल्थ एक्सपर्ट्स का कहना है कि यह तीसरी लहर बच्चों के लिए ज़्यादा खतरनाक होगी। इस खबर ने पेरेंट्स की चिंता को बढ़ा दिया था क्योंकि देश में बच्चों के लिए कोरोना वायरस की कोई वैक्सीन अभी उपलब्ध नहीं है। लेकिन इस बीच बड़ी खुशखबरी ये मिल रही है कि जल्द ही 2 साल से 18 साल तक के बच्चों के लिए आने वाले दिन में कोरोना की वैक्सीन मिल सकती है। भारत बायोटेक की कोवैक्सीन जल्द ही बच्चों के लिए भी उपलब्ध हो जाएगी। आधिकारिक सूत्रों ने कहा है कि मंगलवार को सेंट्रल ड्रग्स स्टैंडर्ड कंट्रोल आर्गेनाईजेशन यानी (CDSCO ) की एक विशेष पैनल ने भारत बायोटेक की कोवाक्सिन को 2 से 18 साल की उम्र के ट्रायल के लिए मंजूरी दे दी है। यह ट्रायल विभिन्न जगहों पर 525 बच्चों पर होगा, जिनमें एम्स दिल्ली, एम्स पटना और मेडिट्रिना इंस्टीट्यूट ऑफ मेडिकल साइंसेज, नागपुर शामिल हैं। कोवैक्सीन पूरी तरह से स्वदेशी है, जिसे भारत बायोटेक ने बनाया है। अभी तक यह वैक्सीन 18 साल से ऊपर से लोगों के लिए ही बनाई गई है।
To Subscribe on Youtube:
https://www.youtube.com/user/punjabkesaritv
Follow us on Twitter :
https://twitter.com/punjabkesari
Like us on FB:
https://www.facebook.com/Pkesarionline/
Coronavirus : कोरोनावायरस की तीसरी लहर से Bharat Biotech की 'Covaxin' बचाएगी बच्चों को !
News video | 514 views
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
#BharatBiotech #Covaxin #CovidVaccine #catchnews #CatchNewsToday
For more videos, subscribe to our channel: https://goo.gl/bkDSLj
Check out Catch News for more news: http://www.catchnews.com/
Follow Catch News here -
Facebook:https://bit.ly/2xD3NKZ
Twitter: https://bit.ly/2NG3rhr
Instagram: https://bit.ly/30mh2vE
--------------------------------------------------------------------------------------------
Also, Follow Catch in Hindi: http://hindi.catchnews.com/
Catch is a contemporary new digital platform about the ideas and events shaping the world. It aims to filter and provide news-on-the-run for an impatient new generation. It offers greater insight for influencers and the deeper consumer of news. When opinions are shrill and polarized, we hope to create a middle ground and build bridges. When there is a set thinking, we hope to stand apart and go against the wind. The world is complex, exciting, layered, evolving, always interesting. We hope to be the same.
Lots of videos and lots more in the pipeline. Stay tuned.
Bharat Biotech’s ‘Covaxin’ Gets Nod By SEC For Phase 2, 3 Trials On 2 to 18 Yrs | Catch News
News video | 340 views
Subject Expert Committee (SEC) gave nod to Bharat Biotech’s ‘Covaxin’ for phase 2 and 3 human clinical trials on 2 to 18 years. In the ongoing vaccination drive in India, the ‘Covaxin’ is being used in adults. ‘Covaxin’ is one of the two vaccines being manufactured in India currently and has been developed by Bharat Biotech.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets SEC nod for phase 2-3 clinical trials on 2 to 18 year-olds
News video | 282 views
Deputy Chief Minister of Delhi, Manish Sisodia said, 'Bharat Biotech wrote to us that they could not give us more doses, the central government is controlling the supply of the vaccine. I would say exporting 6.6 cr doses was the biggest mistake, We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply’. Listen in.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
100 Covaxin sites will shut down as Bharat Biotech unable to provide more doses, says Manish Sisodia
News video | 381 views
The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare. Bharat Biotech will conduct trials in 525 healthy volunteers. 'In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28,' it said.
► Subscribe to The Economic Times for latest video updates. It's free! - http://www.youtube.com/TheEconomicTimes?sub_confirmation=1
► More Videos @ ETTV - http://economictimes.indiatimes.com/TV
► http://EconomicTimes.com
► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp
Follow ET on:
► Facebook - https://www.facebook.com/EconomicTimes
► Twitter - http://www.twitter.com/economictimes
► LinkedIn - http://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes
Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
News video | 354 views
IND vs SA | World Cup T20 2024 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs South Africa in the World Cup T20 2024 season! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the South Africa, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of World Cup T20 2024. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs SA | World Cup T20 2024 | Final | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 11158 views
IND vs ZIM | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Zimbawe in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Zimbawe, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 series. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs ZIM | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 1971 views
Watch as our employees try to guess the famous cricketers from just a few clues. Can you beat them at their own game? Test your cricket knowledge and see how many cricketers you can guess correctly. Don’t forget to like, comment, and subscribe for more fun office challenges and cricket trivia! #CricketChallenge #OfficeFun #guessthecricketer #crickettrivia
Office Fun Challenge: Guess the Cricketers? #office #crictracker #cricketlover ????
Sports video | 1602 views
IND vs BAN | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Bangladesh in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Bangladesh, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 series. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs BAN | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 2671 views
IND vs SL | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Sri Lanka in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Sri Lanka, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 series. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs SL | T20 | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 2292 views
IND vs SL | T20 | Final | Match Preview and Stats | Fantasy 11 | Crictracker
Welcome to the exhilarating showdown between India vs Sri Lanka in the T20 series! Get ready for an electrifying clash as these two powerhouse teams, fueled by raw talent and strategic brilliance, lock horns for cricketing supremacy.
Join us as the India, led by their charismatic captain, face off against the Sri Lanka, determined to showcase their prowess on the pitch. With star-studded lineups boasting top-tier international players and emerging talents, expect nothing short of cricketing excellence and heart-stopping moments.
Don't miss a single moment of the action, drama, and excitement as these teams battle it out in the high-stakes arena of this T20 Final. From breathtaking boundaries to strategic masterstrokes, witness every twist and turn in this epic showdown.
IND vs SL | T20 | Final | Match Preview and Stats | Fantasy 11 | Crictracker
Sports video | 1929 views